Thus, targeting C/EBP-δ may provide an interesting avenue for cancer therapy; through which one could simultaneously target MDSCs and tumor endothelium, two important components in the tumor microenvironment, to achieve killing two birds with one stone. Here, CEBPD is linked to cancer.